Results 41 to 50 of about 6,597 (237)

Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report

open access: yesJournal of Cutaneous Immunology and Allergy, 2023
We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.
Keiji Kosaka   +3 more
doaj   +1 more source

Prurigo pigmentosa: Case report [Prurigo Pigmentoza]

open access: yes, 2016
Prurigo pigmentosa is a rare skin disease of unknown etiology. Prurigo pigmentosa is seen frequently in young Japanese women. It is characterized by pruritic, erythematous macular, papular, papulovesicular lesions and reticular pigmentation.
Acer E.   +3 more
core   +1 more source

Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study

open access: yesActa Dermato-Venereologica, 2023
Narrowband-ultraviolet B has shown increased efficacy over broadband-ultraviolet B in pruritic skin diseases, such as psoriasis and atopic dermatitis. In patients with chronic pruritus, e.g.
Romana Kupsa   +5 more
doaj   +1 more source

Successful Treatment of Severe Adult Linear IgA Dermatosis Using Dupilumab

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Linear IgA dermatosis (LAD) is a rare autoimmune subepidermal bullous dermatosis, characterised by the presence of erythematous vesiculobullous lesions arranged in rosettes or herpetiform clusters. The standard treatment involves the administration of dapsone, followed by sulfasalazine, and general corticosteroid therapy, often in combination ...
Célia Delesalle   +7 more
wiley   +1 more source

Startups Driving Artificial Intelligence Into Clinical Dermatology

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest   +10 more
wiley   +1 more source

Prurigo Pigmentosa Successfully Treated with Oral Minocycline: A Case Report

open access: yes, 2023
Jie Yang,* Xiaohuan Hu,* Mu Niu, Xiaole Zheng Department of Dermatology, The Fifth People’s Hospital of Hainan Province, Haikou, Hainan Province, People’s Republic of China*These authors contributed equally to this workCorrespondence: Mu Niu;
Yang J, Zheng X, Hu X, Niu M
core  

Prurigo nodularis, prurigo chronica új terápiás lehetőségei [PDF]

open access: yes, 2021
Prurigo nodularis (PN) is a skin disease that develops on chronically itchy skin. There are various causes behind the chronic itch. Due to intensive research in recent years different mechanisms that can participate in the development of chronic pruritus
Csörgő Sándorné Bata Zsuzsanna
core   +1 more source

PSEUDOLEUKÆMIC PRURIGO [PDF]

open access: yesThe American Journal of the Medical Sciences, 1903
n ...
openaire   +2 more sources

Canal Cholesteatoma Presentation and Management: A Systematic Review and Meta‐Analysis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To evaluate current understanding of external auditory canal cholesteatoma (EACC), its symptomatic burden, clinical features, diagnostic approach, and management strategies to reduce delays in diagnosis. Data Sources PubMed, CINAHL, COCHRANE Library, and SCOPUS.
Angelica M. Walker   +6 more
wiley   +1 more source

Broadening the View: Substance P and Its Metabolism in Pruritus‐Related Diseases

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Chronic pruritus is a debilitating symptom accompanying numerous inflammatory skin diseases and remains a major therapeutic challenge. Neurogenic inflammation plays a central role in its pathogenesis, with the tachykinin substance P acting as a key mediator at the interface of the nervous system, immune cells, and cutaneous tissues.
Thomas Walter, Bjoern B. Burckhardt
wiley   +1 more source

Home - About - Disclaimer - Privacy